Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia

Infection and Immunity

Volumn 69, Issue 2, 2001, Pages 758-764

  Wright, T W ^a   Notter, R H ^a   Wang, Z ^a   Harmsen, A G ^a   Gigliotti, F ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; PHOSPHOLIPID; PROTEIN; SURFACTANT PROTEIN B;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; INFLAMMATION; LUNG ALVEOLUS SURFACE TENSION; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; MICE; MICE, INBRED C57BL; MICE, SCID; PNEUMONIA, PNEUMOCYSTIS; PULMONARY SURFACTANTS; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0035141939     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.2.758-764.2001     Document Type: Article

References (59)

1. Assay of inorganic phosphate, total phosphate and phosphatases
2. Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins
3. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant
4. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice
5. Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production
6. Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome
7. Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats
8. Pulsating bubble technique for evaluation of pulmonary surfactant
9. Surfactant analysis during Pneumocystis carinii pneumonia in HIV-infected patients
10. Interleukin 3: From colony-stimulating factor to pluripotent immunoregulatory cytokine
11. Surfactant subtypes in experimental lung damage: Radiation pneumonitis
12. Approximations in the measurement of surface tension on the oscillating bubble surfactometer
13. Changes in subphase surfactant aggregates in rabbits injured by free fatty acid
14. Inhibition of pulmonary surfactant by oleic acid: Mechanisms and characteristics
15. Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation
16. + cells in resistance to Pneumocystis carinii pneumonia in mice
17. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia
18. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity
19. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity
20. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids
21. Multiple mechanisms of lung surfactant inhibition
22. Effects of aerosolized synthetic surfactant, atovaquone, and the combination of these on murine Pneumocystis carinii pneumonia
23. Lymphotactin: A cytokine that represents a new class of chemokine
24. Interactions between plasma proteins and pulmonary surfactant: Pulsating bubble studies
25. Inactivation of exogenous surfactant by pulmonary edema fluid
26. Altered surfactant function and metabolism in rabbits with acute lung injury
27. Surfactant and ARDS
28. Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro
29. Pneumocystis carinii glycoprotein A inhibits surfactant phospholipid secretion by rat alveolar type II cells
30. Protein measurement with the Folin phenol reagent
31. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii
32. Pulmonary surfactant: Physical chemistry, physiology, and replacement
33. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages
34. Tumor necrosis factor-α decreases surfactant protein B mRNA in murine lung
35. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators
36. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat
37. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease
38. Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro
39. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10
40. A human T-cell specific molecule is a member of a new gene family
41. Alveolar surfactant and adult respiratory distress syndrome. Pathogenic role and therapeutic prospects
42. Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer
43. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia
44. Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia
45. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury
46. Pneumocystis carinii alters surfactant protein A concentrations in bronchealveolar lavage fluid
47. In vivo effects of interferon-gamma and indomethacin on murine alveolar macrophage activity
48. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice
49. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo
50. Structure and regulation of the murine Clara cell secretory protein gene
51. Plasticity of airway cell proliferation and gene expression after acute naphthalene injury
52. Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats
53. In vitro modulation of induced neutrophil activation by different surfactant preparations
54. Chemokine networks in vivo: Involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-α
55. Additivity of protein and non-protein inhibitors of lung surfactant activity
56. Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein
57. Immune-mediated inflammation directly impairs pulmonary function contributing to the pathogenesis of Pneumocystis pneumonia
58. Dexamethasone increases adult rat surfactant lipids
59. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein